We found that OGD may affect the IDO1/KYN metabolic pathway through IL11, thereby affecting fibroblast senescence and collagen expression, which may provide an effective basis for the treatment of cellular senescence caused by ischemic disease (Figure 11). The gene discussed is IDO1; the disease is ischemic disease.